Humacyte is trading 6% up at $0.69 today, appearing to move in tandem with a broader market rally rather than any stock-specific developments.
- Major indices are all trading more than 0.9% higher, signaling a shift toward positive investor sentiment across the board.
- The price action comes on a relatively quiet news day for the company, with no fresh headline catalysts or developments reported.